Paramectin Drench 0.08% w/v Oral Solution

国家: 英国

语言: 英文

来源: VMD (Veterinary Medicines Directorate)

有效成分:

Ivermectin

可用日期:

Norbrook Laboratories Limited

ATC代码:

QP54AA

INN（国际名称）:

Ivermectin

药物剂型:

Oral solution

处方类型:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

治疗组:

Sheep

治疗领域:

Endectocide

授权状态:

Authorized

授权日期:

2006-11-08

产品特点

Revised: July 2018
AN: 02259/2017
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Paramectin Drench 0.8 mg/ml Oral Solution
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Ivermectin
0.8 mg/ml
EXCIPIENTS:
Benzyl alcohol
30 ml/ml
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Oral solution
A pale yellow clear liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment and control of gastrointestinal nematodes, lungworms and
nasal bots of
sheep
GASTROINTESTINAL WORMS (ADULT AND IMMATURE):
_Haemonchus contortus, Ostertagia circumcincta,_ _ Trichostrongylus _
spp, _ Cooperia _
spp,
_Nematodirus _
spp
including
_N. _
_battus, _
_Strongyloides _
_papillosus_,_ _
_Oesophagostomum _spp, and adult _Chabertia ovina_
Inhibited larval stages and benzimidazole resistant strains of _ H.
contortus_ and
_Ostertagia circumcincta_ are also controlled.
LUNGWORMS_ _(ADULT AND IMMATURE):
_Dictyocaulus filaria_
NASAL BOT (ALL LARVAL STAGES):
_Oestrus ovis_
4.3
CONTRAINDICATIONS
The product has been formulated specifically for use in sheep. It
should not be used
in other species, as severe adverse reactions, including fatalities in
dogs, may occur.
Revised: July 2018
AN: 02259/2017
Page 2 of 5
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
The product is not for intravenous or intramuscular use.
Do not use in sheep producing milk for human consumption.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
•
Underdosing
which
may
be
due
to
underestimation
of
body
weight,
misadministration of the product, or lack of calibration of the dosing
device (if
any).
Suspected clinical cases of resist